drug · protein
patient view →exendin-(9-39)
Phase 2updated 2mo agoby Children's Hospital of Philadelphia🔗 ChEMBL
Phase 2community read0 votes
Protein drug with a maximum clinical stage of Phase 3 (across all indications), with 7 investigational indications.
targets
Glucagon-like peptide 1 receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that